Physician profile
Danni Fu
NPI 1891286720
$2,725.20
in general payments reported to CMS, 2019-2025
13 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $119 · 2023: $86.13 · 2024: $2,142 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Grant: $1,063 · Education: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.49 |
| Grant | $1,063.30 |
| Education | $235.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,214.97 | 2024 | Avvigo Guidance System |
| Shockwave Medical, INC | $619.25 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $209.91 | 2025 | Angiovac |
| Abiomed | $165.45 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $151.69 | 2021 | |
| Medtronic, INC. | $118.73 | 2022 | |
| Pfizer INC. | $55.55 | 2024 | |
| Abbott Laboratories | $52.13 | 2023 | Gallant, Aveir, Assurity |
| Ge Healthcare | $34.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $30.04 | 2024 | |
| Amgen INC. | $29.20 | 2024 | |
| Terumo Medical Corporation | $27.04 | 2024 | Tr Band, Angio-Seal |
| Chiesi USA, INC. | $17.24 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danni Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.